ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 6, June 2026 | pp. 412–419
DOI: 10.46882/AJIDR/148969
Article Type: Research Article
Title: Immunogenicity and neutralizing antibody persistence following heterologous booster vaccination against circulating Dengue virus serotypes
Names of Authors: Mei-Ling Chen¹*, Alejandro Ruiz², Nadia Benali³
Abstract: Dengue virus causes recurrent epidemics across tropical regions, where secondary heterotypic infections carry an elevated risk of severe plasma leakage. We evaluated serotype-specific neutralizing antibody durability following a heterologous dengue vaccine booster regimen in previously primed adults. Serum samples from 196 healthy volunteers were assayed at baseline, day 28, and month 12 using plaque reduction neutralization tests. Geometric mean titers against DENV-1 through DENV-4 remained above protective thresholds in 86.7 percent of participants at one year without antibody-dependent enhancement signals. Heterologous boosting strengthens broad cross-serotype humoral immunity.
Keywords: Dengue virus, Neutralizing antibodies, Heterologous vaccination, Flavivirus, Humoral immunity
Citation: Chen M, Ruiz A, Benali N (2026). Immunogenicity and neutralizing antibody persistence following heterologous booster vaccination against circulating Dengue virus serotypes. African Journal of Infectious Diseases Research, 13(6): 412–419. DOI: 10.46882/AJIDR/148969
Manuscript Timeline: Received: May 03, 2026; Revised: June 03, 2026; Accepted: June 13, 2026; Published: June 21, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read